Archive
87 Posts
“To be blunt…” Alzheimer Amyloid NEJM & JAMA: April 2019
Alzheimer Research & the NIA-AA RF: what did I really want to say? ( with help from Yoda!)
2018: Rx Failure, FDA, $2B, big names, AT(N) biomarkers
Spending $2 Billion on Alzheimer’s: a Fantasy
Eisai-Biogen BAN2401: was I wrong to like the trial last year [Dec 2017] ??
Bill Gates’ $30M for Alz Diagnostics [Jul 2018]: hmmmm….
Bill Gates’ $50M for Alz research [Nov 2017]: wish list!
Alzheimer’s clinical research lacks leadership [headline by Balt Sun, Op-Ed Apr 2017]
